| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2771778 | Seminars in Arthritis and Rheumatism | 2011 | 9 Pages |
Abstract
Despite specific pediatric guidance for monitoring low-dose methotrexate use in juvenile idiopathic arthritis, variation in practice exists in the British Isles. It may be that blood test monitoring could safely be performed less frequently than currently recommended. To inform future changes to guidance, we suggest establishing a prospective registry for serious side effects.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Daniel P. MB, BS, BMedSci, Nikki RSCN, Satyapal MB, BS,